MARKET

IMNN

IMNN

Imunon Inc
NASDAQ
1.480
+0.010
+0.68%
After Hours: 1.430 -0.05 -3.38% 17:29 05/29 EDT
OPEN
1.430
PREV CLOSE
1.470
HIGH
1.480
LOW
1.430
VOLUME
5.75K
TURNOVER
0
52 WEEK HIGH
2.000
52 WEEK LOW
0.4800
MARKET CAP
13.91M
P/E (TTM)
-0.7314
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at IMNN last week (0520-0524)?
Weekly Report · 2d ago
IMUNON INC - EFFECTIVE JUNE 1, 2024, COMPANY APPOINTED DAVID GAIERO TO SERVE AS COMPANY'S NEW CHIEF FINANCIAL OFFICER
Reuters · 05/20 12:32
Weekly Report: what happened at IMNN last week (0513-0517)?
Weekly Report · 05/20 10:57
Imunon files for $75M mixed shelf offering
Seeking Alpha · 05/15 20:56
Imunon Inc. Files For Mixed Shelf Offering Up To $75M - SEC Filing
Benzinga · 05/15 20:27
IMUNON INC FILES FOR MIXED SHELF OF UP TO $75 MLN - SEC FILING
Reuters · 05/15 20:23
Imunon Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/14 11:09
Imunon Price Target Cut to $12.00/Share From $13.00 by HC Wainwright & Co.
Dow Jones · 05/14 11:09
More
About IMNN
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit a strong immunological response. The third modality, FixPlas, concerns the application of Imunon’s DNA technology to produce universal cancer vaccines, also called tumor associated antigen cancer vaccines. The fourth modality, IndiPlas, is in the discovery phase and is focused on the development of personalized cancer vaccines, or neoepitope cancer vaccines. Its lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer.

Webull offers Imunon Inc stock information, including NASDAQ: IMNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMNN stock methods without spending real money on the virtual paper trading platform.